Intelligence Platform
Patents
Browse 1,641 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9187516
Compositions and methods for inhibiting expression of a gene from the Ebola virus
granted patentUS 9181530
Infectious hepatitis E virus genotype 3 recombinants
granted patentUS 9180179
Development of a marker foot and mouth disease virus vaccine candidate that is attenuated
granted patentUS 9181306
Insertion of foreign genes in rubella virus and their stable expression in a live, attenua
granted patentUS 9173886
Antiviral compounds and methods of use thereof
granted patentUS 9174990
2-amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purines as antiviral agents
granted patentUS 9169297
Subgenomic replicons of the flavivirus dengue
granted patentUS 9169296
Expression and assembly of human group C rotavirus-like particles and uses thereof
granted patentUS 9168269
Inhibitors of long and very long chain fatty acid metabolism as broad spectrum anti-virals
granted patentUS 9163068
Influenza virus recombinant proteins
granted patentUS 9163248
Targeting pseudotyped retroviral vectors
granted patentUS 9156818
Hepatitis C virus inhibitors
granted patentUS 9149445
Inhibition of glycerol-3-phosphate acyltransferase (GPAT) and associated enzymes for treat
granted patentUS 9145548
Foot and mouth disease virus with increased stability and its use as vaccine
granted patentUS 9144605
Recombinant rift valley fever virus encoding a dominant-negative inhibitor of DSRNA-depend
granted patentUS 9139575
Broad spectrum antiviral and antiparasitic agents
granted patentUS 9139620
Feline morbillivirus and uses thereof
granted patentUS 9133478
Modified vaccinia Ankara (MVA) virus recombinants comprising heterologous coding sequences
granted patentUS 9133462
dsRNA for treating viral infection
granted patentUS 9133480
Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertio
granted patentUS 9127021
Hepatitis C virus inhibitors
granted patentUS 9115187
Identification of antibodies specific for lyssaviruses and methods of their use
granted patentUS 9109014
Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vacc
granted patentUS 9097713
Monoclonal antibodies against glycoprotein of Ebola sudan boniface virus
granted